These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24755002)

  • 21. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test.
    Retnakaran R; Zinman B; Connelly PW; Sermer M; Hanley AJ
    Diabetes Care; 2006 Jan; 29(1):57-62. PubMed ID: 16373896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial and Autonomic Dysfunction at Early Stages of Glucose Intolerance and in Metabolic Syndrome.
    Dimova R; Tankova T; Kirilov G; Chakarova N; Grozeva G; Dakovska L
    Horm Metab Res; 2020 Jan; 52(1):39-48. PubMed ID: 31529423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of factors associated with changes in the oral glucose tolerance test, regardless of the values of fasting glucose].
    Lauria MW; Dias IN; Soares MM; Cordeiro GV; Barbosa VE; Ramos AV
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):708-13. PubMed ID: 22231974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy.
    Brufani C; Ciampalini P; Grossi A; Fiori R; Fintini D; Tozzi A; Cappa M; Barbetti F
    Pediatr Diabetes; 2010 Feb; 11(1):47-54. PubMed ID: 19460122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uric acid, impaired fasting glucose and impaired glucose tolerance in youth with overweight and obesity.
    Di Bonito P; Valerio G; Licenziati MR; Campana G; Del Giudice EM; Di Sessa A; Morandi A; Maffeis C; Chiesa C; Pacifico L; Baroni MG; Manco M
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):675-680. PubMed ID: 33272808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.
    Alikaşifoğlu A; Gönç N; Özön ZA; Sen Y; Kandemir N
    J Clin Res Pediatr Endocrinol; 2009; 1(5):233-9. PubMed ID: 21274300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children.
    Groot CJ; Grond JV; Delgado Y; Rings EH; Hannema SE; van den Akker EL
    J Pediatr Endocrinol Metab; 2017 Feb; 30(2):189-196. PubMed ID: 28076317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
    Love-Osborne K; Butler N; Gao D; Zeitler P
    Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome.
    Coles N; Bremer K; Kives S; Zhao X; Hamilton J
    J Pediatr Adolesc Gynecol; 2016 Feb; 29(1):48-52. PubMed ID: 26358939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inside out the Ragbag of Glucose Intolerance in Obese Adolescents.
    Brufani C; Tura A; Bedogni G; Luciano R; Sbrignadello S; Fintini D; Cappa M; Weiss R; Manco M
    Horm Res Paediatr; 2017; 87(5):287-294. PubMed ID: 28391281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral glucose effectiveness and metabolic risk in obese children and adolescents.
    Spreghini N; Cianfarani S; Spreghini MR; Brufani C; Morino GS; Inzaghi E; Convertino A; Fintini D; Manco M
    Acta Diabetol; 2019 Aug; 56(8):955-962. PubMed ID: 30868315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated glucose level at 30 minutes during an oral glucose tolerance test in obese adolescents: a new disorder of glucose tolerance.
    Kabaroğlu C; Ersoy B; Onur E; Özhan B; Erdin S; Var A; Bayındır O; Dinç G
    Endocr J; 2013; 60(2):197-205. PubMed ID: 23095208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of traits of metabolic syndrome with glucose abnormalities.
    Hoffmann IS; Cubeddu LX
    Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort.
    Ilanne-Parikka P; Eriksson JG; Lindström J; Hämäläinen H; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Mannelin M; Rastas M; Salminen V; Aunola S; Sundvall J; Valle T; Lahtela J; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2004 Sep; 27(9):2135-40. PubMed ID: 15333474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.
    de Ferranti SD; Gauvreau K; Ludwig DS; Neufeld EJ; Newburger JW; Rifai N
    Circulation; 2004 Oct; 110(16):2494-7. PubMed ID: 15477412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.